NCT00414518View on ClinicalTrials.gov

Safety and Effectiveness of Short-Term Anti-HIV Drug Therapy for Recent HIV-1 Infection

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions
HIV Infections
Interventions
DRUG

Tenofovir disoproxil fumarate/Emtricitabine

300 mg Tenofovir disoproxil fumarate/ 200 mg emtricitabine tablet taken orally once daily

DRUG

Lopinavir/Ritonavir

Three 400 mg lopinavir/ 100 mg ritonavir soft gel capsules taken orally twice daily

Trial Locations (3)

30308

AIDS Research Consortium of Atlanta, Atlanta

80262

University of Colorado Health Sciences Center, Denver

Unknown

University of Zimbabwe College of Health Sciences, Harare

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

University of Colorado, Denver

OTHER

NCT00414518 - Safety and Effectiveness of Short-Term Anti-HIV Drug Therapy for Recent HIV-1 Infection | Biotech Hunter | Biotech Hunter